18th Edition (August 5, 2011)
- Modified Khorana Risk Score for Prediction of Venous Thromboembolic Events (VTE) in Patients with Cancer
- Classifications of Acute Kidney Injury and Chronic Kidney Disease
- Criteria for Neurosurgical or Neuroradiologic Intervention for Mold Infections of the Central Nervous System (CNS)
- Criteria for the Diagnosis of Obsessive–Compulsive Disorder (OCD)
- Case Definition for Ebola Virus Disease (EVD)
|Indications for Therapy and for Neurosurgery in Patients with Prolactinomas|
|Written by G. Firman MD|
|Thursday, 08 April 2010 03:52|
In contrast to macroadenomas, for which therapy is routinely indicated, microadenomas do not always require treatment. For patients with microadenomas who do not have these indications, symptoms and prolactin levels can be monitored, and MRI can be used to follow the size of the tumor.
Indications for Therapy in Patients with Prolactinomas
Given the efficacy of medical therapy, only a small minority of patients with prolactinomas require transsphenoidal surgery or radiation therapy. Surgical cure rates, which are highly dependent on surgical skill and tumor anatomy, approach 80 to 90% for microadenomas but are less than 50% for macroadenomas.
Indications for Neurosurgery in Patients with Prolactinomas
Created: Abr 08, 2010.
Newer news items:
Older news items:
|Last Updated on Friday, 29 August 2014 04:06|
Site Last Modified